Crohn's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Crohn's Disease, including details on symptoms, diagnosis, treatment, causes, medication.

Volume 2 (2005), Issue 7 (July)

1. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations.
   Arthritis Rheum, 52(7): 1993-8. [Abstract] [Full-text]
2. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation.
   Dis Colon Rectum, 48(7): 1416-23. [Abstract] [Full-text]
3. Crohn's disease: presentation and severity compared between black patients and white patients.
   Dis Colon Rectum, 48(7): 1404-9. [Abstract] [Full-text]
4. High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.
   Clin Exp Immunol, 141(2): 357-62. [Abstract] [Full-text]
5. The comparative importance of E. coli antigen in granulomatous colitis of Boxer dogs.
   APMIS, 113(6): 420-5. [Abstract] [Full-text]
6. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
   J Clin Microbiol, 43(7): 3380-9. [Abstract] [Full-text]
7. Vulval Crohn's disease-- a multi-specialty approach.
   Int J STD AIDS, 16(7): 512-4. [Abstract] [Full-text]
8. NOD2 mutation and mice: no Crohn's disease but many lessons to learn.
   Trends Mol Med, 11(7): 307-9. [Abstract] [Full-text]
9. Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease.
   Aliment Pharmacol Ther, 22(2): 111-22. [Abstract] [Full-text]
10. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
    Aliment Pharmacol Ther, 22(2): 101-10. [Abstract] [Full-text]
11. Events at the host-microbial interface of the gastrointestinal tract. V. Paneth cell alpha-defensins in intestinal host defense.
    Am J Physiol Gastrointest Liver Physiol, 289(2): G173-6. [Abstract] [Full-text]
12. Chorioamnionitis associated with Crohn's disease and azathioprine treatment: a case report.
    J Med Microbiol, 54: 803-4. [Abstract] [Full-text]
13. Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease.
    Am J Physiol Gastrointest Liver Physiol, 289(2): G361-6. [Abstract] [Full-text]
14. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.
    Dis Colon Rectum, 48(8): 1542-9. [Abstract] [Full-text]
15. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
    Scand J Gastroenterol, 40(6): 670-80. [Abstract] [Full-text]
16. Essential fatty acid depletion in children with inflammatory bowel disease.
    Scand J Gastroenterol, 40(5): 573-7. [Abstract] [Full-text]
17. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Clin Exp Immunol, 141(3): 549-57. [Abstract] [Full-text]
18. Defects in mucosal immunity leading to Crohn's disease.
    Immunol Rev, 206: 277-95. [Abstract] [Full-text]
19. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
    N Engl J Med, 353(4): 362-8. [Abstract] [Full-text]

© 2004-2008 Crohn's Disease Research Today. All Rights Reserved.